Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward Export SNPs

QuickView for SPI1 (gene)


Gene Symbol:
SPI1 Homo sapiens Homo sapiens
Full name:
Spi-1 proto-oncogene
Synonyms:
OF, PU.1, SFPI1, SPI-1, SPI-A, transcription factor PU.1, 31 kDa transforming protein, hematopoietic transcription factor PU.1, spleen focus forming virus (SFFV) proviral integration oncogene spi1
Genomic Location:
Chr 11: 47332985-47356703
Description:
This gene encodes an ETS-domain transcription factor that activates gene expression during myeloid and B-lymphoid cell development. The nuclear protein binds to a purine-rich sequence known as the PU-box found near the promoters of target genes, and regulates their expression in coordination with other transcription factors and cofactors. The prote...
Orthologs:
Mus musculus Rattus norvegicus Macaca mulatta Danio rerio Gallus gallus Pan troglodytes Bos taurus Canis lupus familiaris
External Links:
Entrez Gene
Transcription Factor
Binding Sites:
miRNA binding sites
(Source: TargetScan):
Cytogenetic Map:
chr 11
11p11.2


Protein Names
P17947



GO Molecular Function

sequence-specific DNA binding | transcription regulatory region DNA binding | RNA polymerase II transcription factor activity, sequence-specific DNA binding | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding | enhancer binding | proximal promoter sequence-specific DNA binding | nucleic acid binding | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding | NFAT protein binding | enhancer sequence-specific DNA binding | RNA polymerase II regulatory region DNA binding | DNA binding | sequence-specific double-stranded DNA binding | transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | organic cyclic compound binding | transcription regulatory region sequence-specific DNA binding | protein binding | RNA polymerase II proximal promoter sequence-specific DNA binding | double-stranded DNA binding | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding | DNA-binding transcription factor activity | transcription factor binding | RNA polymerase II transcription factor binding | RNA polymerase II regulatory region sequence-specific DNA binding | transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | RNA polymerase II distal enhancer sequence-specific DNA binding | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | heterocyclic compound binding | RNA binding

GO Biological Process

RNA metabolic process | transcription by RNA polymerase II | positive regulation of macromolecule biosynthetic process | somatic stem cell population maintenance | peptidyl-amino acid modification | erythrocyte homeostasis | regulation of DNA methylation | regulation of immune system process | myeloid cell differentiation | negative regulation of cellular process | RNA polymerase II transcription factor activity, sequence-specific DNA binding | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding | pri-miRNA transcription by RNA polymerase II | negative regulation of RNA biosynthetic process | histone modification | cell differentiation | response to drug | histone H3 acetylation | regulation of organelle organization | anatomical structure regression | response to antibiotic | blood vessel morphogenesis | positive regulation of cellular biosynthetic process | cellular process | regulation of gene expression, epigenetic | lymphocyte differentiation | chromatin organization | lymphoid progenitor cell differentiation | immune system development | negative regulation of nucleic acid-templated transcription | stem cell population maintenance | regulation of histone modification | myeloid dendritic cell differentiation | regulation of myeloid cell differentiation | positive regulation of nitrogen compound metabolic process | negative regulation of peptidyl-lysine acetylation | negative regulation of cellular metabolic process | regulation of cell differentiation | regulation of cellular process | leukocyte activation | regulation of metabolic process | organic cyclic compound metabolic process | RNA biosynthetic process | cellular aromatic compound metabolic process | cellular component organization | response to stimulus | vasculature development | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding | cellular nitrogen compound biosynthetic process | tube morphogenesis | hematopoietic progenitor cell differentiation | programmed cell death | response to alcohol | cardiovascular system development | peptidyl-lysine acetylation | macrophage differentiation | cellular nitrogen compound metabolic process | cellular response to toxic substance | cellular response to ethanol | myeloid dendritic cell activation | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding | negative regulation of metabolic process | positive regulation of RNA biosynthetic process | hemopoiesis | protein modification process | cellular biosynthetic process | macromolecule modification | negative regulation of histone H4 acetylation | blood vessel development | myeloid cell homeostasis | response to ethanol | regulation of nucleic acid-templated transcription | leukocyte differentiation | apoptotic process | negative regulation of MHC class II biosynthetic process | system development | nitrogen compound metabolic process | cellular response to antibiotic | multicellular organism development | protein acetylation | regulation of gene expression | regulation of histone H4 acetylation | myeloid leukocyte differentiation | negative regulation of gene expression, epigenetic | positive regulation of cellular metabolic process | regulation of pri-miRNA transcription by RNA polymerase II | regulation of nitrogen compound metabolic process | regulation of transcription by RNA polymerase II | transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | homeostasis of number of cells | granulocyte differentiation | histone acetylation | internal peptidyl-lysine acetylation | biosynthetic process | regulation of cellular protein metabolic process | aromatic compound biosynthetic process | positive regulation of pri-miRNA transcription by RNA polymerase II | response to toxic substance | hypermethylation of CpG island | cellular response to drug | regulation of cellular metabolic process | regulation of protein metabolic process | apoptotic process involved in development | homeostatic process | regulation of RNA metabolic process | lymphocyte activation | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding | protein metabolic process | DNA-binding transcription factor activity | response to organic substance | regulation of hemopoiesis | DNA hypermethylation | anatomical structure development | metabolic process | dendritic cell differentiation | regulation of RNA biosynthetic process | negative regulation of transcription, DNA-templated | negative regulation of histone acetylation | regulation of erythrocyte differentiation | peptidyl-lysine modification | transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | nucleobase-containing compound metabolic process | organic substance metabolic process | maintenance of cell number | cell death | negative regulation of biosynthetic process | negative regulation of gene expression | animal organ development | negative regulation of cellular protein metabolic process | gene expression | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | regulation of chromosome organization | transcription, DNA-templated | cell activation | negative regulation of protein metabolic process | negative regulation of chromosome organization | covalent chromatin modification | regulation of transcription, DNA-templated | internal protein amino acid acetylation | cellular protein metabolic process | anatomical structure morphogenesis | cellular macromolecule biosynthetic process | regulation of developmental process | developmental process | organelle organization | erythrocyte differentiation | cellular protein modification process | regulation of histone acetylation | negative regulation of transcription by RNA polymerase II | tube development | positive regulation of transcription, DNA-templated | positive regulation of nucleic acid-templated transcription | negative regulation of protein acetylation | positive regulation of transcription by RNA polymerase II | heterocycle metabolic process | positive regulation of metabolic process | chromosome organization | apoptotic process involved in morphogenesis | immune system process | cellular metabolic process | hematopoietic or lymphoid organ development | cellular response to organic substance | circulatory system development | regulation of cellular component organization | apoptotic process involved in blood vessel morphogenesis | positive regulation of gene expression | macromolecule metabolic process | multicellular organismal process | regulation of chromatin organization

GO Cellular Component

chromosome | intracellular membrane-bounded organelle | cell | nuclear lumen | intracellular organelle | nucleoplasm | chromatin | nuclear chromosome | membrane-bounded organelle | nucleus | organelle | membrane-enclosed lumen | nuclear chromatin | intracellular